Abstract
Chronic Kidney Disease (CKD) is characterized by the progressive and irreversible loss ofkidney functions. Currently, the therapeutic arsenal used to control CKD is limited toapplication of RAAS inhibitor drugs, diuretics and immunosuppressive drugs, eventuallyrelated to side effects. Recent data in the literature have shown that the application ofmesenchymal stem cells (MSC) in the kidne…